CROI 2024 Day 3 Evaluation: Tuesday, March 5, 2024

Please complete the following evaluation. We appreciate your feedback and comments on the program. If you start the evaluation but are not able to complete it in “one sitting,” your progress will be saved as you go so long as you are using the same device and do not clear your cache in your browser.

Question Title

* How are you participating in CROI 2024?

In-person

Virtually

Question Title

* General comments: Please comment on any element of the conference day 3

Question Title

* Please select your role at CROI 2024. (Check all that apply.)

Presenting Author

Coauthor

General Attendee

Invited Speaker/Moderator/Leader

Community Educator

Scholarship Awardee

External Reviewer

Program Committee Member

Please evaluate the Tuesday session(s) that you attended. If you did not attend a session, please skip those evaluation questions (or mark N/A).

TUESDAY PLENARY SESSION
8:30 AM – 9:30 AM

Session Hosts: Stuart J. D. Neil and Constance A. Benson

Question Title

* HIV Assembly, Maturation Inhibitors, and Drug Resistance
Eric O. Freed

	Excellent	Very Good	Good	Fair	Poor	N/A
Content	Content Excellent	Content Very Good	Content Good	Content Fair	Content Poor	Content N/A
Effectiveness of speaker’s teaching methods	Effectiveness of speaker’s teaching methods Excellent	Effectiveness of speaker’s teaching methods Very Good	Effectiveness of speaker’s teaching methods Good	Effectiveness of speaker’s teaching methods Fair	Effectiveness of speaker’s teaching methods Poor	Effectiveness of speaker’s teaching methods N/A
Value to your clinical, research, or other responsibility	Value to your clinical, research, or other responsibility Excellent	Value to your clinical, research, or other responsibility Very Good	Value to your clinical, research, or other responsibility Good	Value to your clinical, research, or other responsibility Fair	Value to your clinical, research, or other responsibility Poor	Value to your clinical, research, or other responsibility N/A
Freedom from commercial bias	Freedom from commercial bias Excellent	Freedom from commercial bias Very Good	Freedom from commercial bias Good	Freedom from commercial bias Fair	Freedom from commercial bias Poor	Freedom from commercial bias N/A

Please comment:

Question Title

* Accelerating Tuberculosis Elimination: Short-Course Prevention and Treatment
Vidya Mave

	Excellent	Very Good	Good	Fair	Poor	N/A
Content	Content Excellent	Content Very Good	Content Good	Content Fair	Content Poor	Content N/A
Effectiveness of speaker’s teaching methods	Effectiveness of speaker’s teaching methods Excellent	Effectiveness of speaker’s teaching methods Very Good	Effectiveness of speaker’s teaching methods Good	Effectiveness of speaker’s teaching methods Fair	Effectiveness of speaker’s teaching methods Poor	Effectiveness of speaker’s teaching methods N/A
Value to your clinical, research, or other responsibility	Value to your clinical, research, or other responsibility Excellent	Value to your clinical, research, or other responsibility Very Good	Value to your clinical, research, or other responsibility Good	Value to your clinical, research, or other responsibility Fair	Value to your clinical, research, or other responsibility Poor	Value to your clinical, research, or other responsibility N/A
Freedom from commercial bias	Freedom from commercial bias Excellent	Freedom from commercial bias Very Good	Freedom from commercial bias Good	Freedom from commercial bias Fair	Freedom from commercial bias Poor	Freedom from commercial bias N/A

Please comment:

Question Title

* How are you participating in CROI 2024?

Question Title

* General comments: Please comment on any element of the conference day 3

Question Title

* Please select your role at CROI 2024. (Check all that apply.)

Question Title

* HIV Assembly, Maturation Inhibitors, and Drug ResistanceEric O. Freed

Question Title

* Accelerating Tuberculosis Elimination: Short-Course Prevention and TreatmentVidya Mave

Question Title

* What changes to your clinical, research, or other responsibility will you make as a result of this plenary session?

* HIV Assembly, Maturation Inhibitors, and Drug Resistance
Eric O. Freed

* Accelerating Tuberculosis Elimination: Short-Course Prevention and Treatment
Vidya Mave